Skip to content

Effects of Music Breathing Training Combined with Singing Techniques in Pulmonary Rehabilitation for COPD Patients: a Randomized Controlled Trial

Effects of Music Breathing Training Combined with Singing Techniques in Pulmonary Rehabilitation for COPD Patients: a Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000211
Enrollment
Unknown
Registered
2026-01-28
Start date
2026-02-09
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

Music Therapy Group:In addition to receiving basic pharmacological treatment, participants underwent music breathing exercises and singing under the guidance of a music therapist. Each session lasted
Traditional Therapy Group:In addition to receiving basic pharmacological treatment, participants received conventional pulmonary rehabilitation under the guidance of a physical therapist. Each session

Sponsors

The Fifth Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) First, meet the diagnostic criteria for Chronic Obstructive Pulmonary Disease (COPD) as outlined in the 2024 GOLD guidelines: presence of chronic respiratory symptoms (dyspnea, cough, sputum production) due to airway (bronchitis, bronchiolitis) and/or alveolar abnormalities (emphysema), and/or a history of exposure to risk factors such as environmental or genetic factors, with a post-bronchodilator FEV1/FVC < 70%. Specifically:FEV1% = 80% indicates GOLD Grade 1 (mild), 50%–79% indicates GOLD Grade 2 (moderate), 30%–49% indicates GOLD Grade 3 (severe), < 30% indicates GOLD Grade 4 (very severe). (2) Age between 40 and 75 years (inclusive); (3) GOLD Grades 2–4: FEV1% = 79%; (4) Ability to walk independently; (5) Adequate cognitive and verbal function; (6) Willingness to voluntarily participate in the study and provide signed informed consent after the investigator has explained the study purpose.

Exclusion criteria

Exclusion criteria: (1) History of acute exacerbation of chronic obstructive pulmonary disease within the past 2 weeks; (2) Patients with comorbid psychiatric disorders, or those with cognitive impairment, severe neurological deficits (e.g., aphasia, agnosia), severe hearing impairment, or other conditions that may hinder cooperation; (3) Patients with comorbid active tuberculosis, pulmonary fibrosis, pneumothorax, lung cancer, etc.; (4) Patients with severe systemic diseases affecting the heart, kidneys, liver, muscles, etc.; (5) Patients requiring mechanical ventilation; (6) Individuals with an aversion to music; (7) Patients currently participating in other clinical trials; (8) Other reasons deemed by the investigator as unsuitable for participation in this trial.

Design outcomes

Primary

MeasureTime frame
6 minutes walking test;

Secondary

MeasureTime frame
Forced Expiratory Volume in 1 second / Forced Vital Capacity;modified Medical Research Council (mMRC);COPD Assessment Test(CAT);Borg scale;

Countries

China

Contacts

Public ContactYajing Xue

The Fifth Affiliated Hospital of Guangzhou Medical University

xueyajing2016@163.com+86 191 2055 6778

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 13, 2026